NL188981C - Farmaceutisch preparaat met kankerbestrijdende werking, alsmede antrachinonderivaten die geschikt zijn als werkzaam bestanddeel daarvan. - Google Patents

Farmaceutisch preparaat met kankerbestrijdende werking, alsmede antrachinonderivaten die geschikt zijn als werkzaam bestanddeel daarvan.

Info

Publication number
NL188981C
NL188981C NLAANVRAGE7808475,A NL7808475A NL188981C NL 188981 C NL188981 C NL 188981C NL 7808475 A NL7808475 A NL 7808475A NL 188981 C NL188981 C NL 188981C
Authority
NL
Netherlands
Prior art keywords
anthrachine
active substance
pharmaceutical preparation
cancer effect
derivatives suitable
Prior art date
Application number
NLAANVRAGE7808475,A
Other languages
English (en)
Dutch (nl)
Other versions
NL7808475A (nl
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27542240&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL188981(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US05/903,292 external-priority patent/US4138415A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NL7808475A publication Critical patent/NL7808475A/xx
Application granted granted Critical
Publication of NL188981C publication Critical patent/NL188981C/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
    • G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J45/00—Ion-exchange in which a complex or a chelate is formed; Use of material as complex or chelate forming ion-exchangers; Treatment of material for improving the complex or chelate forming ion-exchange properties
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/40—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
    • C08G59/62—Alcohols or phenols
    • C08G59/621—Phenols
    • C08G59/623—Aminophenols
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/68—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the catalysts used
    • C08G59/686—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the catalysts used containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M1/00—Liquid compositions essentially based on mineral lubricating oils or fatty oils; Their use as lubricants
    • C10M1/08—Liquid compositions essentially based on mineral lubricating oils or fatty oils; Their use as lubricants with additives
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M133/00—Lubricating compositions characterised by the additive being an organic non-macromolecular compound containing nitrogen
    • C10M133/02—Lubricating compositions characterised by the additive being an organic non-macromolecular compound containing nitrogen having a carbon chain of less than 30 atoms
    • C10M133/04—Amines, e.g. polyalkylene polyamines; Quaternary amines
    • C10M133/12—Amines, e.g. polyalkylene polyamines; Quaternary amines having amino groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NLAANVRAGE7808475,A 1977-08-15 1978-08-15 Farmaceutisch preparaat met kankerbestrijdende werking, alsmede antrachinonderivaten die geschikt zijn als werkzaam bestanddeel daarvan. NL188981C (nl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US82487277A 1977-08-15 1977-08-15
US87304078A 1978-01-30 1978-01-30
US87317478A 1978-01-30 1978-01-30
US87304178A 1978-01-30 1978-01-30
US05/903,292 US4138415A (en) 1978-05-05 1978-05-05 1,4-Bis(aminoalkylamino)-anthraquinones and leuco derivatives thereof

Publications (2)

Publication Number Publication Date
NL7808475A NL7808475A (nl) 1979-02-19
NL188981C true NL188981C (nl) 1992-12-01

Family

ID=27542240

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7808475,A NL188981C (nl) 1977-08-15 1978-08-15 Farmaceutisch preparaat met kankerbestrijdende werking, alsmede antrachinonderivaten die geschikt zijn als werkzaam bestanddeel daarvan.

Country Status (22)

Country Link
JP (1) JPS6463556A (fr)
AR (1) AR225884A1 (fr)
AT (1) AT359484B (fr)
AU (1) AU527103B2 (fr)
BE (1) BE869688A (fr)
CH (1) CH644840A5 (fr)
DD (1) DD139256A5 (fr)
DE (1) DE2835661A1 (fr)
DK (1) DK158836C (fr)
FI (1) FI70882C (fr)
FR (1) FR2400504A1 (fr)
GB (1) GB2004293B (fr)
GR (1) GR74415B (fr)
IE (1) IE47253B1 (fr)
IL (1) IL55218A (fr)
IT (1) IT1107773B (fr)
NL (1) NL188981C (fr)
NO (2) NO148777C (fr)
NZ (1) NZ187989A (fr)
PL (1) PL122586B1 (fr)
PT (1) PT68420A (fr)
SE (1) SE445996B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4275009A (en) * 1979-05-29 1981-06-23 American Cyanamid Company 1-(Aminoalkylamino)-5,8-dihydroxy-4-substituted-anthraquinones
US4275010A (en) * 1979-10-24 1981-06-23 American Cyanamid Company 5,8-Dihydroxy-1,4-bis(guanidinylamino)anthraquinones
US4296030A (en) * 1980-04-09 1981-10-20 American Cyanamid Company Metal chelates of 1,4-bis(substituted-amino-5,8-dihydroxy-anthraquinones
US4278605A (en) * 1980-06-30 1981-07-14 American Cyanamid Company Heteroalkylenebisanthraquinones
EP0052853A1 (fr) * 1980-11-24 1982-06-02 Hoechst Aktiengesellschaft Dérivés de la bis-aminométhyl-anthraquinone, leur procédé de préparation, compositions les contenant et leur application
EP0083683A1 (fr) * 1981-10-26 1983-07-20 American Cyanamid Company Procédé pour préparer de 1,4-bis(amino substitués)-5,8-dihydroxy-anthraquinones et compositions pharmaceutiques les contenant
EP0154117B1 (fr) * 1984-02-27 1989-12-27 American Cyanamid Company Utilisation des anthrachinones 1,4 bi-substitueés pour la fabrication des medicaments immunosuppresives
EP0182135A3 (fr) * 1984-11-19 1987-08-05 American Cyanamid Company Aminoanthraquinones bis-N-substituées
US5436243A (en) * 1993-11-17 1995-07-25 Research Triangle Institute Duke University Aminoanthraquinone derivatives to combat multidrug resistance
GB9815910D0 (en) 1998-07-21 1998-09-23 Btg Int Ltd Synthetic method
US7557215B2 (en) * 2003-12-23 2009-07-07 Somanta Limited Anthraquinone compounds as anti cancer compounds
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
EA019341B1 (ru) 2008-12-23 2014-02-28 Джилид Фармассет, Ллс. Фосфорамидаты нуклеозидов
PA8855701A1 (es) 2008-12-23 2010-07-27 Análogos de nucleósidos
WO2010075554A1 (fr) 2008-12-23 2010-07-01 Pharmasset, Inc. Synthèse de nucléosides de type purine
BR112012024884A2 (pt) 2010-03-31 2016-10-18 Gilead Pharmasset Llc síntese estereosseletiva de ativos contendo fósforo
DE102012203981A1 (de) * 2012-03-14 2013-09-19 Henkel Ag & Co. Kgaa Mittel zum Färben und/oder Mattieren von keratinhaltigen Fasern enthaltend neuartige1,4-Diaminoanthrachinonfarbstoffe
GB201214169D0 (en) 2012-08-08 2012-09-19 Biostatus Ltd New compounds and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1422016A (fr) * 1962-10-29 1965-12-24 Oreal Nouveaux colorants anthraquinoniques et leur application à la teinture des cheveux
GB1157506A (en) * 1965-09-10 1969-07-09 Ilford Ltd Anthraquinone Dye Colour Couplers and their use in Colour Photographic Materials
US3646072A (en) * 1970-07-27 1972-02-29 Du Pont Turquoise biscationic anthraquinone dyes
US3700398A (en) * 1970-07-27 1972-10-24 Du Pont Process for dyeing acid-modified nylon fibers
US4051155A (en) * 1975-12-15 1977-09-27 Allied Chemical Corporation Anthraquinone dyes

Also Published As

Publication number Publication date
NO782756L (no) 1979-02-16
AU527103B2 (en) 1983-02-17
SE7807987L (sv) 1979-02-16
AT359484B (de) 1980-11-10
SE445996B (sv) 1986-08-04
NO148777C (no) 1984-01-25
PL122586B1 (en) 1982-08-31
IL55218A (en) 1983-03-31
IT7850730A0 (it) 1978-08-14
IT1107773B (it) 1985-11-25
AR225884A1 (es) 1982-05-14
GB2004293B (en) 1982-06-23
NL7808475A (nl) 1979-02-19
GB2004293A (en) 1979-03-28
DD139256A5 (de) 1979-12-19
NO150482C (no) 1984-10-24
NO150482B (no) 1984-07-16
FI70882C (fi) 1986-10-27
JPH0217534B2 (fr) 1990-04-20
DE2835661C2 (fr) 1991-08-22
DK158836B (da) 1990-07-23
JPS6463556A (en) 1989-03-09
ATA590678A (de) 1980-04-15
FI782481A (fi) 1979-02-16
FR2400504A1 (fr) 1979-03-16
IE47253B1 (en) 1984-02-08
NO148777B (no) 1983-09-05
DE2835661A1 (de) 1979-03-01
FI70882B (fi) 1986-07-18
NZ187989A (en) 1981-07-13
PL209065A1 (fr) 1980-01-02
NO820290L (no) 1979-02-16
AU3877678A (en) 1980-02-14
FR2400504B1 (fr) 1981-06-26
IE781636L (en) 1979-02-15
PT68420A (en) 1978-09-01
BE869688A (fr) 1979-02-12
DK358678A (da) 1979-02-16
GR74415B (fr) 1984-06-28
CH644840A5 (de) 1984-08-31
DK158836C (da) 1991-01-14

Similar Documents

Publication Publication Date Title
NL7802792A (nl) Cefem- en cefam-verbindingen met antimicrobiele werking, werkwijzen ter bereiding daarvan, als- mede farmaceutische preparaten die deze verbin- dingen als actieve component bevatten.
NL7805278A (nl) Aminoalkylthiofeenderivaten met selectieve werking op histamine-receptoren, alsmede werkwijzen ter bereiding daarvan en farmaceutische preparaten die deze derivaten als actief component bevatten.
NL176670C (nl) Farmaceutisch preparaat met antivirale werking en voor gebruik als aktieve stof in een dergelijk preparaat geschikte verbindingen.
NL188981C (nl) Farmaceutisch preparaat met kankerbestrijdende werking, alsmede antrachinonderivaten die geschikt zijn als werkzaam bestanddeel daarvan.
NL7803195A (nl) Heterocyclische verbindingen met farmaceutische activiteit, werkwijzen ter bereiding daarvan, alsmede farmaceutische preparaten, die deze verbindingen als actieve component bevatten.
NL980013I2 (nl) Gesubstitueerde benzhydrylpiperidinederivaten met therapeutische werking en preparaten die deze stoffen bevatten.
NL173978C (nl) Fysiologisch werkzame verbinding, esterastine genaamd, en werkwijze voor het bereiden daarvan langs microbiologische weg, alsmede farmaceutische preparaten met immunosuppressieve werking die de verbinding bevatten.
IT7829043A0 (it) Polisaccaride avente attivita'anti-tumorale, procedimento per lasua produzione e sostanza anti-tumorale comprendente detto polisaccaride.
NL190664C (nl) Gesubstitueerde benzhydrylpiperidinoderivaten met therapeutische werking en farmaceutische preparaten die deze verbindingen bevatten.
NL190552C (nl) 1-Fenyl-4-alkyl-7,8-dialkoxy-5H-2,3-benzodiazepinederivaten en farmaceutische preparaten, die deze bevatten.
NL188692C (nl) Benzhydrylsulfinylaceetamide- en (n,n-difenylcarbamoyl)-aceetamide-derivaten, alsmede farmaceutisch preparaat daaruit met werking op het centrale zenuwstelsel.
NL184467B (nl) 6-oxo-prostaglandine eŸ1 derivaten, werkwijze voor de bereiding daarvan en farmaceutische preparaten, die deze bevatten.
NL7803162A (nl) Nieuwe 1-aminoindaanderivaten, alsmede farmaceutische preparaten die deze bevatten.
NL950027I1 (nl) Alfa-halogeenmethyl-alfa-aminozuurderivaten en farmaceutisch preparaat die dit bevat.
NL187397C (nl) Farmaceutische preparaten, 20,21-dinoreburnamenineverbindingen daarvoor en werkwijze voor hun bereiding.
NL188981B (nl) Farmaceutisch preparaat met kankerbestrijdende werking, alsmede antrachinonderivaten die geschikt zijn als werkzaam bestanddeel daarvan.
NL7811135A (nl) Digesubstitueerde piperazinen, werkwijze voor de bereiding ervan en geneesmiddelen met dergelijke verbindingen erin als werkzaam bestanddeel.
NL188944C (nl) Werkwijze voor het bereiden van omega-aminoalkoxybenzeenderivaten alsmede werkwijze voor het bereiden van farmaceutische preparaten met toepassing daarvan, als werkzame verbinding.
NL173273B (nl) Werkwijze ter bereiding van een geneesmiddel met antibiotische werking, gevormd geneesmiddel met antibiotische werking, alsmede werkwijze ter bereiding van geneeskrachtige verbindingen, die als actieve verbinding in genoemde preparaten kunnen worden gebruikt.
NL7510259A (nl) Uridinederivaat alsmede farmaceutisch preparaat.
NL7808303A (nl) Benzylalcoholderivaten met bloedsuikerspiegel verlagen- de werking, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL188579C (nl) 3-(tetrazol-5-yl)-1-azaxanthonen, alsmede farmaceutische preparaten die deze verbindingen bevatten.
NL180070C (nl) Therapeutisch preparaat met kankerbestrijdende werking.
NL7705561A (nl) Farmaceutisch preparaat en werkwijzen voor de bereiding en toepassing ervan.
NL7902993A (nl) Nieuwe isochinolinederivaten, de bereiding ervan en farmaceutische preparaten, die de nieuwe isochinoline- derivaten bevatten.

Legal Events

Date Code Title Description
BT A notification was added to the application dossier and made available to the public
BT A notification was added to the application dossier and made available to the public
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BT A notification was added to the application dossier and made available to the public
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 980815